Fourrts India

Active ingredient

LMONTUS – Levocetirizine dihydrochloride 5 mg + Montelukast Sodium 10 mg

LMONTUS KID – Levocetirizine dihydrochloride 2.5 mg + Montelukast Sodium 4 mg

LMONTUS KID FORTE – Levocetirizine dihydrochloride 2.5 mg + Montelukast Sodium 5 mg

LMONTUS SUSPENSION – Levocetirizine dihydrochloride 2.5 mg + Montelukast Sodium 4 mg / 5ML

Allergic Rhinitis , Asthma

Once Daily

LMONTUS is a combination of montelukast sodium & levocetirizine dihydrochloride. Montelukast sodium is an orally active compound that binds with high affinity and selctivity to the CysLt type-1 (CysLT1) receptor. Montelukast inhibits physiologic actions of LTD4 at the CysLT1 receptor without any agonist activity. It therefore acts as leukotriene receptor antagonist Levocetirizine, the active enantiomer of cetirizine, is an antihistamine and selective antagonist of H1-receptors. It has been demonstrated by recent studies that the treatment of allergic rhinitis (AR) with concomitant administration of an antileukotriene (montelukast) and an antihistamine (levocetirizine), shows significantly better symptom relief compared with the modest improvement of rhinitis symptomatology with each of the treatments alone.